Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Augmenting clozapine with sertindole (SERCLOZ)
2006-002682-40Phase 4Completed
- Sponsor
- Unit for Psychiatric Research
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in schizophrenia comparing clozapine + sertindole with clozapine + placebo (2 arms). Primary endpoint: PANSS reduction at 12 weeks. Started Aug 2006; status: completed.
02
Drugs
sertindole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2006-002682-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002682-40.